Search Tag: Executive Chair

2024 21 Mar

  Theolytics, a biotechnology company developing  category changing cancer therapies in the form of oncolytic viruses, announced the appointment of Michael (Mike) Grey succeeding Dr. Ken Powell, who is retiring from the Board having served as Chair since 2019.   This appointment comes at a pivotal time for Theolytics as the Company advances its...Read more